课题基金 / 基金详情

Control of synovitis using gene therapy.

Control of synovitis using gene therapy.
使用基因疗法控制滑膜炎。
批准号:
12557127
负责人:
KUBO Toshikazu
金额:
$8.06万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

KUBO Toshikazu的其他基金

相似基金

相关文献

中文摘要
翻译
寻找更安全的载体用于临床基因治疗是非常必要的。因此,我们选择了相对安全的非病毒载体。首先,用三种阳离子聚合物将LacZ基因导入软骨细胞样细胞系(HCS2/8),X-Gal染色和ONPG法检测LacZ基因的表达。其中以聚酰胺胺(PAMAM)树枝状大分子效果最好,显示了非病毒载体的应用价值。将这种阳离子聚合物和基于EBV的质粒载体注射到大鼠关节内,可以提高体内的转导效率。然后,我们采用体内电穿孔的效果。将含有标记基因的EB病毒载体注射到大鼠膝关节内,用一对特殊电极施加不同电压的电脉冲。基因表达在150V时达到最高水平,明显好于阳离子聚合物。我们对细胞凋亡信号调节蛋白激酶(ASK)-1基因的研究很感兴趣。该基因在细胞中的表达有望诱导细胞凋亡。将携带ASK-1基因的腺病毒载体感染单层培养的人类风湿滑膜细胞。在Hoechst 33342染色中,60h后,约50%的细胞被诱导凋亡。在本研究中,我们通过与其他非病毒载体的比较,发现了电穿孔在体内将基因转导到滑膜组织中的有效性,并证明了ASK-1通过转导到滑膜来治疗滑膜炎的可能性。
英文摘要
It is needed for us to explore safer vector for gene therapy in clinical use. So we chose non-virus vectors that are relatively safe. Firstly, LacZ gene was transduced to chondrocytes-like cell line (HCS2/8) by three types of cationic polymer and this gene expression was evaluated by X-gal staining and ONPG assay. Polyamidoamine (PAMAM) dendrimer was most effective in three, and it showed the usefulness of non-virus vector. Injections into rat joints with this cationic polymer and EBV-based plasmid vector were found to improve the transduction efficacy in vivo. Then we employed the efficacy of electroporation in vivo. EBV-based plasmid vector containing marker gene was injected into rat knee joints and different voltages of electric pulses were applied with a pair of special electrodes. The gene expression reached the highest level in 150V, and it was much better than with cationic polymers. We took an interest in apoptosis signal regulating kinase (ASK) -1 gene. The expression of this gene in cells was expected to induce apoptosis. Adenovirus vector containing ASK-1 gene was infected to the human rheumatoid synovious cells placed in monolayer culture. In Hoechst 33342 staining assay, 60 hours later, apoptosis was induced in about 50% of cells. In this study, we found the usefulness of the electroporation for gene transduction to synovious tissue in vivo, compared with other non-virus vectors and showed the possibility that ASK-1 would be effective for synovitis by transducing to synovium.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
久保俊一, 他: "関節疾患に対する遺伝子治療の開発"京府医大誌. 110. 719-730 (2001)
Shunichi Kubo 等:“关节疾病基因治疗的发展”京都医科大学杂志 110. 719-730 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
久保 俊一, 他: "軟骨細胞に対する遺伝子治療"現代医療. 33(5). 1225-1229 (2000)
Shunichi Kubo 等人:“软骨细胞的基因治疗”现代医学 33(5) 1225-1229 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
久保俊一, 他: "軟骨細胞に対する遺伝子治療"現代医療. 33. 1225-1229 (2000)
Shunichi Kubo 等:“软骨细胞的基因治疗”现代医学 33. 1225-1229 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
久保俊一, 他: "関節疾患に対する非ウイルスベクターを用いた遺伝子導入法"整形外科. 51. 839-845 (2000)
Shunichi Kubo 等:“使用非病毒载体治疗关节疾病的基因转移方法”Orthopedics 51. 839-845 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    The analysis of thermotherapy combined with drugs for osteoarthritis
    • 批准号:
      23650333
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KUBO Toshikazu
    • 依托单位:
    The analysis of cellular stress response towards novel conservative therapies for joint disease
    • 批准号:
      20390404
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2008
    • 负责人:
      KUBO Toshikazu
    • 依托单位:
    development of novel conservative therapies for joint disease under controlled HSP expression-usage of HSP-inducing agents and thermotherapy-
    • 批准号:
      17390419
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.98万
    • 财政年份:
      2005
    • 负责人:
      KUBO Toshikazu
    • 依托单位:
    Mechanical response of chondrocyte under intermittent hydrostatic pressure loading.-Regeneration of Articular Cartilage
    • 批准号:
      15390464
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2003
    • 负责人:
      KUBO Toshikazu
    • 依托单位:
    海外基金